Le Lézard
Classified in: Science and technology
Subject: Product/Service

Guardsquare Augments Free Mobile App Security Testing Product With Enterprise-Ready Version


Guardsquare, the mobile application security provider, today announced the company's award-winning free mobile application security testing (MAST) product, AppSweep, is now available in an enterprise version to help organizations scale their ability to find and address security risks across multiple teams working at different stages of mobile app builds. AppSweep Enterprise facilitates access across teams, compliance with IT security policies and seamlessly integrates with existing tools and systems.

Now available in both free and paid versions, Guardsquare's introduction of AppSweep Enterprise provides organizations with the ability to seamlessly integrate with existing business tools and processes while also scaling to meet the needs of growing teams. With this latest release, organizations can now:

AppSweep helps developers quickly find and - with the actionable recommendations within the product - solve security issues in Android and iOS app code and dependencies, based on security standards such as OWASP MASVS. Built for mobile, AppSweep automates the testing of mobile apps leveraging different analysis techniques to obtain relevant, actionable findings about an app's code through static analysis (SAST) and dynamic analysis (DAST/IAST) at runtime. AppSweep is now available in both free and Enterprise versions.

"I am proud of the ongoing evolution of AppSweep as we continue our quest to make mobile app security testing accessible to organizations of all sizes - now in both free and paid versions," said Roel Caers, CEO of Guardsquare.

"AppSweep has become our go-to mobile applications security testing tool, with its low rate of false positives and actionable advice to avoid security issues," says a leading financial services provider. "We leverage AppSweep's automation capabilities to routinely trigger security scans without burdening the DevSecOps team, resulting in the most secure mobile experience for our customers."

For more information about AppSweep, visit: https://www.guardsquare.com/appsweep-mobile-application-security-testing

About Guardsquare
Guardsquare offers the most complete approach to mobile application security on the market. Built on the open-source Proguard technology, Guardsquare's software integrates seamlessly across the development cycle. From app security testing to code hardening and real-time visibility into the threat landscape, Guardsquare solutions provide enhanced mobile application security from early in the development process through publication. More than 900 customers worldwide across all major industries rely on Guardsquare to help them identify security risks and protect their mobile applications against reverse engineering and tampering.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: